Chronic Myeloid Leukemia

Common Name(s)

Chronic Myeloid Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myeloid Leukemia" returned 1365 free, full-text research articles on human participants. First 3 results:

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.
 

Author(s): E Glodkowska-Mrowka, A Manda-Handzlik, A Stelmaszczyk-Emmel, I Seferynska, T Stoklosa, J Przybylski, P Mrowka

Journal:

 

Last Updated: 9 Jan 2016

Go To URL
Real-time quantitative PCR detection of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia.
 

Author(s): Annamária Szántó, Zsuzsánna Pap, Lóránd Dénes, Erzsébet Benedek Lázár, Adrienne Horváth, Alíz Beáta Tunyogi, Beáta Ágota Baróti, Zoltán Pávai

Journal: Rom J Morphol Embryol. 2015 ;56(2 Suppl):703-7.

 

The Philadelphia chromosome and the resulting BCR-ABL fusion gene represent the hallmark event in chronic myeloid leukemia (CML) and their discoveries radically changed the management of these patients. Currently Wilms tumor 1 gene (WT1) is intensively investigated as high WT1 expression ...

Last Updated: 2 Oct 2015

Go To URL
Major progress in understanding progression in chronic myeloid leukemia.
 

Author(s): Jerry Radich

Journal: J. Exp. Med.. 2015 Sep;212(10):1482.

 

Last Updated: 22 Sep 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myeloid Leukemia" returned 143 free, full-text review articles on human participants. First 3 results:

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
 

Author(s): L Wang, F Du, H-M Zhang, H-X Wang

Journal: Braz. J. Med. Biol. Res.. 2015 Jul;48(7):583-7.

 

We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients. Moreover, both shared the variant encoding p.Pro737His, but the aCML severity was greater in the son ...

Last Updated: 9 Jul 2015

Go To URL
Diagnosing and managing advanced chronic myeloid leukemia.
 

Author(s): Michael W Deininger

Journal: Am Soc Clin Oncol Educ Book. 2015 ;():e381-8.

 

Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural history in the absence of effective therapy. Morphologically, transformation from CP-CML to AP/BP-CML is ...

Last Updated: 21 May 2015

Go To URL
Therapeutic drug monitoring of imatinib, nilotinib, and dasatinib for patients with chronic myeloid leukemia.
 

Author(s): Masatomo Miura

Journal: Biol. Pharm. Bull.. 2015 ;38(5):645-54.

 

Imatinib, nilotinib, and dasatinib are tyrosine kinase inhibitors (TKIs) that have become first-line treatments for Philadelphia chromosome-positive chronic myeloid leukemia (CML). According to European LeukemiaNet recommendations, the clinical response of CML patients receiving TKI ...

Last Updated: 7 May 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
 

Status: Recruiting

Condition Summary: Chronic Phase Philadelphia Positive; BCR-ABL Positive; Chronic Myeloid Leukaemia

 

Last Updated: 22 Feb 2015

Go to URL
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
 

Status: Recruiting

Condition Summary: Chronic Myeloid Leukemia

 

Last Updated: 26 May 2015

Go to URL
TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
 

Status: Recruiting

Condition Summary: Chronic Myeloid Leukemia

 

Last Updated: 18 May 2013

Go to URL